Our results show that GABPA stable silencing does not universally reduce TERT transcription in TERT-mutant thyroid cancer cells and that it also controls TERT wildtype promoter (e.g., in Cal62 cells). This evidence concerns the gene GABPA and thyroid gland carcinoma.